Lead party: Royal Bafokeng Holdings (Pty) Ltd (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Dis-Chem Pharmacies Limited (public company) · Sector: Consumer Discretionary, Drug Retailers · Countries of operation: Namibia, South Africa, Botswana
Transaction type: Merger/Acquisition(M&A) · Asset class: Private Equity · Instrument: Equity · Deal amount: US$156.9m · Equity stake: 0.105% · Implied EV: US$1.49bn · Fund: GloCap Empowerment Fund 6
Lead investor/buyer: Royal Bafokeng Holdings (Pty) Ltd · Investors/buyers: Zungu Pharmaceuticals, Temo Capital , Zico, Glocap, Royal Bafokeng Holdings (Pty) Ltd
Legal advisers: not identified in the source record.
Source: announced 24 August 2021. Original announcement: bizcommunity.com.


